- Home
- ALT vs NFGC Comparison
ALT vs NFGC Comparison
Compare ALT & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | NFGC |
|---|---|---|
| Founded | 1997 | 2016 |
| Country | United States | Canada |
| Employees | N/A | 138 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 573.8M | 672.6M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALT | NFGC |
|---|---|---|
| Price | $3.06 | $1.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 922.5K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,000.00 | N/A |
| Revenue This Year | N/A | $3,542.00 |
| Revenue Next Year | N/A | $118.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 105.00 | N/A |
| 52 Week Low | $2.56 | $1.34 |
| 52 Week High | $6.44 | $3.59 |
Technical Indicators
Market Signals| Indicator | ALT | NFGC |
|---|---|---|
| Relative Strength Index (RSI) | 43.24 | 50.28 |
| Support Level | $3.02 | $1.62 |
| Resistance Level | $3.09 | $2.08 |
| Average True Range (ATR) | 0.14 | 0.08 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 13.16 | 57.14 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Companies exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).